Vaccines: United States Report
This report forecasts to 2029 US vaccine and other product shipments nominal US dollars at the manufacturer level.
Free Sample Report
Request a free sample of this report and our team will email it to you.
Report Overview
This report forecasts to 2029 US vaccine and other product shipments nominal US dollars at the manufacturer level. To illustrate historical trends, total shipments are provided in annual series from 2019 to 2024.
Vaccine and other product shipments include the distribution of vaccines, toxoids, blood fractions, and culture media of plant or animal origin (excluding diagnostics), as defined by NAICS 325414. These products are manufactured for immunization or therapeutic use and shipped to healthcare providers, distributors, and public health agencies.
Key macroeconomic indicators are also provided with quantified trends. Other various topics, including profiles of pertinent leading companies, are covered in this report. A full outline of report items by page is available in the Table of Contents.
Related NAICS Codes
| NAICS Code | Code Description |
|---|---|
| 325414 | Biological Product (except Diagnostic) Manufacturing |
Table of Contents
HIGHLIGHTS- Historical Trends
- Key Economic Indicators
- Environmental & Regulatory Factors
- Technological Advancements
- Key Influencing Factors
- Industry Characteristics
- Market Leaders
- Scope
- Sources
- Industry Codes
- Freedonia Methodology
- Resources
